Online citations, reference lists, and bibliographies.
← Back to Search

Long-term Results Of Treatment Of Idiopathic Blepharospasm With Botulinum Toxin Injections.

J. Elston
Published 1987 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
One hundred and one patients with idiopathic blepharospasm have been treated with injections of botulinum toxin A into the orbicularis oculi. Ten had previously had facial nerve avulsions and responded well, normal visual function being restored in the majority (7/10) for an average of 14 weeks. Without prior surgical treatment the response was more variable, but 71/91 regained normal or near normal vision. Older patients, those with a family history of the condition, and those without oromandibular dystonia responded slightly better. The severity of the blepharospasm, the length of the history, and spontaneous resolution of an episode of focal dystonia in the past had no influence on the outcome. Results were poor in the presence of an associated neurological disorder. Side effects, particularly a temporary partial ptosis, were common but were well tolerated. The average duration of improvement was eight weeks in men, nine in women, and there was no evidence of any increase in duration after multiple injections. Eighty nine patients continued with injections, 11 opted for surgical treatment, and one resumed drugs.
This paper references
10.1113/jphysiol.1974.sp010608
Observations on the action of type A botulinum toxin on frog neuromuscular junctions
D. A. Boroff (1974)
10.1001/ARCHOPHT.1984.01040031184014
Treatment of blepharospasm with botulinum toxin. A preliminary report.
B. Frueh (1984)
Pharmacologic weakening of extraocular muscles.
A. B. Scott (1973)
gas gangrene and clostridium gastrointestinal infections
H E Larson (1982)
10.1016/0002-9394(86)90601-X
Absence of antibody production in patients treated with botulinum A toxin.
A. W. Biglan (1986)
Observations on the action of botulinum toxin A on the frog neuromuscular junction
D A Boroff (1974)
10.1016/0022-510X(71)90129-8
An electron microscopic study of the changes induced by botulinum toxin in the motor end-plates of slow and fast skeletal muscle fibres of the mouse.
L. Duchen (1971)
Pharmacological weakening of extra-ocular muscles
A B Scott (1973)
10.1016/0022-510X(71)90130-4
Changes in the electron microscopic structure of slow and fast skeletal muscle fibres of the mouse after the local injection of botulinum toxin.
L. Duchen (1971)
10.1002/ANA.410130406
Blepharospasm and orofacial‐cervical dystonia: Clinical and pharmacological findings in 100 patients
J. Jankovic (1983)
10.1001/ARCHOPHT.1981.03930011056015
Blepharospasm surgery. An anatomical approach.
W. Gillum (1981)
Treatment of blcpharospasm with botulinum toxin
B R Freuh (1984)
10.3928/0191-3913-19800101-06
Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery.
A. B. Scott (1980)
10.1136/bmj.290.6485.1857
Effect of treatment with botulinum toxin on neurogenic blepharospasm.
J. Elston (1985)
10.1016/S0161-6420(80)35127-0
Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery.
A. B. Scott (1980)
10.1001/ARCHOPHT.1985.01050030043017
Botulinum A toxin injection as a treatment for blepharospasm.
A. Scott (1985)
10.1097/00007611-197312000-00017
Essential Blepharospasm
William H. Coles (1973)
Light and electron microscopic changes in slow and fast skeletal muscle fibres and their motor end-plates in the mouse after the local injection of tetanus toxin.
L. Duchen (1972)
10.1056/NEJM198110153051618
Choline for blepharospasm.
B. Skarf (1981)



This paper is referenced by
10.1007/978-1-4614-5836-4_169
Botulinum neurotoxins as therapeutics
Raja Mehanna (2014)
10.1007/978-3-642-84478-2_321
Behandlung des Torticollis spasmodicus mit lokalen Injektionen von Botulinum Toxin - 1-Jahres-Ergebnisse bei 37 Patienten
W. Poewe (1991)
10.1016/j.survophthal.2010.03.008
Review and update of involuntary facial movement disorders presenting in the ophthalmological setting.
A. Ross (2011)
10.1016/S0002-9394(03)00075-8
Quantitative changes in botulinum toxin a treatment over time in patients with essential blepharospasm and idiopathic hemifacial spasm.
M. Snir (2003)
10.1007/978-3-642-77064-7_6
Botulinumtoxin A in der Behandlung der zervikalen Dystonien
R. Benecke (1993)
10.1016/J.SURVOPHTHAL.2006.10.003
Botulinum toxin in ophthalmology.
J. Dutton (2007)
10.1016/S0039-6257(97)81995-9
Botulinum-A toxin in the treatment of craniocervical muscle spasms: short- and long-term, local and systemic effects.
J. Dutton (1996)
10.1111/J.1442-9071.1994.TB00793.X
Efficacy and side effects of botulinum toxin treatment for blepharospasm and hemifacial spasm.
J. Price (1994)
10.1136/PGMJ.65.762.208
Effect of treatment with botulinum toxin on spasticity.
T. K. Das (1989)
10.1016/j.jns.2016.11.053
Meige's syndrome: History, epidemiology, clinical features, pathogenesis and treatment
Sanjay Pandey (2017)
10.1016/S0987-7053(96)85003-9
Mécanisme d'action, indication et résultats des traitements par la toxine botulinique
A. Lagueny (1996)
10.1002/MUS.880171207
Serial neurophysiological studies of intramuscular botulinum‐A toxin in humans
J. A. Hamjian (1994)
10.1002/MDS.870070212
Severe but temporary injury to rabbit orbicularis oculi muscle using dihematoporphyrin ether and laser photochemomyectomy
J. Wirtschafter (1992)
10.1007/978-1-4614-4466-4
Craniofacial Muscles
L. McLoon (2013)
10.3109/01658109709009684
Pupillometry after botulinum: A toxin treatment
P. Schnider (1997)
10.1007/s00702-010-0546-9
Difficulties with differentiating botulinum toxin treatment effects in essential blepharospasm
B. Wabbels (2010)
10.1111/j.1755-3768.1990.tb01933.x
Long‐term treatment of involuntary facial spasms using botulinum toxin
P. Ruusuvaara (1990)
10.1001/ARCHOTOL.1988.01860240057024
Management of facial spasm with Clostridium botulinum toxin, type A (Oculinum)
A. W. Biglan (1988)
10.1007/BF00839206
Treatment of spasmodic torticollis with local injections of botulinum toxin
W. Poewe (2004)
10.1001/ARCHOTOL.125.6.627
Long-term enhancement of botulinum toxin injections by upper-eyelid surgery in 14 patients with facial dyskinesias.
J. Mauriello (1999)
10.1136/BJO.75.12.737
Natural history of treatment of facial dyskinesias with botulinum toxin: a study of 50 consecutive patients over seven years.
J. Mauriello (1991)
10.1016/B978-012088445-2/50063-9
CHAPTER 58 – Medical applications of botulinum neurotoxins
Eric A. Johnson (2006)
10.1136/BJO.80.12.1073
Treatment selections of 239 patients with blepharospasm and Meige syndrome over 11 years.
J. Mauriello (1996)
10.1016/0039-6257(91)90207-V
Botulinum A toxin (Oculinum) in ophthalmology.
M. Osako (1991)
10.1038/sj.eye.6702054
Blepharospasm and hemifacial spasm: a protocol for titration of botulinum toxin dose to the individual patient and for the management of refractory cases
E. Ortisi (2006)
10.1590/S1678-91992006000100007
Preliminary studies with a neurotoxin obtained from Bungarus caeruleus venom
K. K. Mirajkar (2006)
10.1097/IOP.0000000000000263
Effect of Upper Eyelid Myectomy on Subsequent Chemodenervation in the Management of Benign Essential Blepharospasm
Tiffany L. Kent (2015)
10.1016/j.jns.2012.01.019
Botulinum toxins in the treatment of primary focal dystonias
Daniel Dung Truong (2012)
10.1016/0275-5408(95)00137-9
Botulinum neurotoxin A in ophthalmology.
C. Bentley (1996)
10.1016/0303-8467(96)00025-X
Treatment choices of 119 patients with hemifacial spasm over 11 years
J. Mauriello (1996)
10.1016/B978-0-7506-9322-6.50028-3
CHAPTER 19 – Diseases of the Eyelids
J. D. Bartlett (1989)
10.1007/PL00007813
Botulinum toxin: evidence-based medicine criteria in blepharospasm and hemifacial spasm
W. Jost (2001)
See more
Semantic Scholar Logo Some data provided by SemanticScholar